2.44
60 Degrees Pharmaceuticals Inc stock is traded at $2.44, with a volume of 32,667.
It is down -3.56% in the last 24 hours and up +21.39% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$2.53
Open:
$2.48
24h Volume:
32,667
Relative Volume:
0.04
Market Cap:
$4.11M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.2447
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+12.96%
1M Performance:
+21.39%
6M Performance:
-63.58%
1Y Performance:
-84.75%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SXTP
60 Degrees Pharmaceuticals Inc
|
2.44 | 4.11M | 502.40K | -7.91M | -4.32M | -9.972 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
443.40 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
318.25 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
560.04 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
254.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Cut to Sell at Wall Street Zen - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
60 Degrees Pharmaceuticals and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Daily Jeffersonian
Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series - The Holland Sentinel
Research Analysts Set Expectations for SXTP Q2 Earnings - Defense World
Insider Buying: Cheryl Xu Acquires Additional Shares of 60 Degre - GuruFocus
Insider Buying: Cheryl Xu Acquires Additional Shares of 60 Degrees Pharmaceuticals Inc (SXTP) - GuruFocus
60 degrees pharmaceuticals director Cheryl Xu purchases $14,410 in stock By Investing.com - Investing.com Nigeria
60 degrees pharmaceuticals director Cheryl Xu purchases $14,410 in stock - Investing.com Australia
60 degrees pharmaceuticals director Cheryl Xu buys $14,410 in stock - Investing.com
60 degrees pharmaceuticals director Cheryl Xu buys $14,410 in stock By Investing.com - Investing.com South Africa
New to The Street Signs MUSQ ETF to Multi-Part Media Series Featuring Long-Form Interviews, Earned Media, and TV Commercials - Sarasota Herald-Tribune
60 Degrees Pharmaceuticals Inc (SXTP) Has A Gold Mine On Its Hands - Stocksregister
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals - mx.advfn.com
60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - mx.advfn.com
SXTP60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - mx.advfn.com
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - mx.advfn.com
60 Degrees Pharmaceuticals introduces new malaria drug packaging By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals (SXTP) Launches New ARAKODA Packaging for Short Trips | SXTP Stock News - GuruFocus
Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) - The Manila Times
60 Degrees announces results from an insurance claims analysis on babesiosis - Yahoo Finance
Only FDA-Approved Weekly Malaria Prevention Drug Now Available in Travel-Friendly 8-Count Package - Stock Titan
60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesi - GuruFocus
60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesiosis and Chronic Fatigue | SXTP Stock News - GuruFocus
Gulf Keystone Petroleum (OTCMKTS:GUKYF) Trading 5.9% Higher – Should You Buy? - Defense World
PROG Holdings, Inc. (NYSE:PRG) Short Interest Update - Defense World
Mobileye Global Inc. (NASDAQ:MBLY) Given Consensus Rating of “Hold” by Analysts - Defense World
Polar Power, Inc. (NASDAQ:POLA) Sees Significant Decline in Short Interest - Defense World
Woodside Energy Group Ltd (NYSE:WDS) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Goldmoney (OTCMKTS:XAUMF) Shares Up 0.6% – Still a Buy? - Defense World
FTI Foodtech International (CVE:FTI) Stock Price Up 2.3% – Still a Buy? - Defense World
Stelco (OTCMKTS:STZHF) Shares Up 1.1% – What’s Next? - Defense World
Trevi Therapeutics (NASDAQ:TRVI) Given “Buy” Rating at D. Boral Capital - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
iShares ESG Aware MSCI EM ETF (NASDAQ:ESGE) Short Interest Update - Defense World
Southwest Gas Holdings, Inc. (NYSE:SWX) Sees Large Increase in Short Interest - Defense World
Muscle Maker (NASDAQ:GRIL) Trading Down 4.2% – What’s Next? - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Price Target Raised to $7.00 at Ascendiant Capital Markets - Defense World
CIIG Merger (OTCMKTS:CIICU) Trading Down 5.1% – Here’s What Happened - Defense World
Kidoz (CVE:KIDZ) Trading 2.9% Higher – Should You Buy? - Defense World
Ascendiant Capital lowers 60 Degrees stock price target to $7 By Investing.com - Investing.com South Africa
Ascendiant Capital Raises Price Target for SXTP to $7.00 | SXTP Stock News - GuruFocus
Ascendiant Capital lowers 60 Degrees stock price target to $7 - Investing.com
Ulta Beauty (NASDAQ:ULTA) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Uber Technologies, Inc. (NYSE:UBER) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World
Lazard Asset Management LLC Acquires New Position in FARO Technologies, Inc. (NASDAQ:FARO) - Defense World
Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida
Cetera Investment Advisers Has $876,000 Stock Holdings in Goldman Sachs BDC, Inc. (NYSE:GSBD) - Defense World
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):